Nspire
PrivateLast Round
Accelerator
Nov 12, 2024
Est. Valuation
$3.12M
Total Funding Raised
$142,500
Company Overview
Nspire operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was an Accelerator round in November 2024.
Nspire is a medical device company that develops novel neonatal nasal cannulas designed to optimize oxygen delivery and improve health outcomes for premature infants.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nspire Comparables
Compare Nspire with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medline, Inc. | 48% | |
| Vapotherm | 48% | |
| Hamilton Medical AG | 44% |
For institutional investors. Book with your work email.
Nspire Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Nspire Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| mHUB | Accelerator |
Nspire Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nspire's valuation, stock price, and market status.
Is Nspire a public or private company?
Nspire is a private company.
What is the current stock price of Nspire?
Nspire is a private company, so its shares have no public market price. Caplight tracks Nspire's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nspire worth (valuation)?
Nspire's valuation is estimated at $3.1M based on funding round data.
Can I buy Nspire stock?
Nspire shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nspire's last funding round?
Nspire's most recent funding round was Accelerator on November 12, 2024.
Who are the main investors in Nspire?
Key investors in Nspire include mHUB.
Will Nspire IPO soon?
No public IPO plans have been announced for Nspire.
How can I track Nspire secondary market activity?
Caplight tracks bids, offers, and trades in Nspire's shares on secondary markets.